Logo image of ASG.CA

AURORA SPINE CORP (ASG.CA) Stock Fundamental Analysis

TSX-V:ASG - CA05206X1087 - Common Stock

0.27 CAD
-0.02 (-6.9%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

3

Overall ASG gets a fundamental rating of 3 out of 10. We evaluated ASG against 14 industry peers in the Health Care Equipment & Supplies industry. ASG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ASG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ASG had negative earnings in the past year.
In the past year ASG had a positive cash flow from operations.
In the past 5 years ASG always reported negative net income.
In multiple years ASG reported negative operating cash flow during the last 5 years.
ASG.CA Yearly Net Income VS EBIT VS OCF VS FCFASG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M

1.2 Ratios

The Return On Assets of ASG (-9.23%) is better than 92.86% of its industry peers.
ASG's Return On Equity of -26.29% is amongst the best of the industry. ASG outperforms 92.86% of its industry peers.
Industry RankSector Rank
ROA -9.23%
ROE -26.29%
ROIC N/A
ROA(3y)-12.48%
ROA(5y)-12.6%
ROE(3y)-29.77%
ROE(5y)-27.75%
ROIC(3y)N/A
ROIC(5y)N/A
ASG.CA Yearly ROA, ROE, ROICASG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

ASG's Gross Margin of 59.63% is fine compared to the rest of the industry. ASG outperforms 64.29% of its industry peers.
ASG's Gross Margin has improved in the last couple of years.
ASG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.72%
GM growth 5Y13.74%
ASG.CA Yearly Profit, Operating, Gross MarginsASG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

More info and screens

5

2. Health

2.1 Basic Checks

ASG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ASG has been increased compared to 1 year ago.
Compared to 5 years ago, ASG has more shares outstanding
The debt/assets ratio for ASG is higher compared to a year ago.
ASG.CA Yearly Shares OutstandingASG.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ASG.CA Yearly Total Debt VS Total AssetsASG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of 0.15, we must say that ASG is in the distress zone and has some risk of bankruptcy.
ASG's Altman-Z score of 0.15 is amongst the best of the industry. ASG outperforms 85.71% of its industry peers.
The Debt to FCF ratio of ASG is 14.76, which is on the high side as it means it would take ASG, 14.76 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 14.76, ASG belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
A Debt/Equity ratio of 0.81 indicates that ASG is somewhat dependend on debt financing.
The Debt to Equity ratio of ASG (0.81) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 14.76
Altman-Z 0.15
ROIC/WACCN/A
WACC7.06%
ASG.CA Yearly LT Debt VS Equity VS FCFASG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

A Current Ratio of 2.02 indicates that ASG has no problem at all paying its short term obligations.
The Current ratio of ASG (2.02) is better than 78.57% of its industry peers.
A Quick Ratio of 1.13 indicates that ASG should not have too much problems paying its short term obligations.
ASG's Quick ratio of 1.13 is fine compared to the rest of the industry. ASG outperforms 78.57% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.13
ASG.CA Yearly Current Assets VS Current LiabilitesASG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.79% over the past year.
The Revenue has grown by 15.34% in the past year. This is quite good.
Measured over the past years, ASG shows a quite strong growth in Revenue. The Revenue has been growing by 9.51% on average per year.
EPS 1Y (TTM)21.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.57%
Revenue 1Y (TTM)15.34%
Revenue growth 3Y18.54%
Revenue growth 5Y9.51%
Sales Q2Q%10.05%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ASG.CA Yearly Revenue VS EstimatesASG.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ASG.CA Yearly EPS VS EstimatesASG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 -0.1 -0.2 -0.3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ASG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASG.CA Price Earnings VS Forward Price EarningsASG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ASG indicates a rather cheap valuation: ASG is cheaper than 85.71% of the companies listed in the same industry.
ASG's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ASG is cheaper than 92.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF 60.87
EV/EBITDA 72.94
ASG.CA Per share dataASG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ASG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AURORA SPINE CORP

TSX-V:ASG (8/29/2025, 7:00:00 PM)

0.27

-0.02 (-6.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-20 2025-08-20
Earnings (Next)10-22 2025-10-22
Inst Owners0%
Inst Owner ChangeN/A
Ins Owners25.16%
Ins Owner ChangeN/A
Market Cap20.85M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.84
P/FCF 60.87
P/OCF 17.49
P/B 3.67
P/tB 4.53
EV/EBITDA 72.94
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY1.64%
OCF(TTM)0.02
OCFY5.72%
SpS0.32
BVpS0.07
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.23%
ROE -26.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.63%
FCFM 1.39%
ROA(3y)-12.48%
ROA(5y)-12.6%
ROE(3y)-29.77%
ROE(5y)-27.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.72%
GM growth 5Y13.74%
F-Score5
Asset Turnover1.53
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 14.76
Debt/EBITDA 13.36
Cap/Depr 63.34%
Cap/Sales 3.44%
Interest Coverage N/A
Cash Conversion 344.63%
Profit Quality N/A
Current Ratio 2.02
Quick Ratio 1.13
Altman-Z 0.15
F-Score5
WACC7.06%
ROIC/WACCN/A
Cap/Depr(3y)69.84%
Cap/Depr(5y)82.94%
Cap/Sales(3y)4.27%
Cap/Sales(5y)5.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.34%
Revenue growth 3Y18.54%
Revenue growth 5Y9.51%
Sales Q2Q%10.05%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y116.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y223.29%
OCF growth 3YN/A
OCF growth 5Y319.03%